1 - 25 of 58 results for author:"Forssmann W.-G." in Literature citations
Results Customize
› Repeat search in UniProtKB (100)
| Naturally occurring fragments from two distinct regions of the prostatic acid phosphatase form amyloidogenic enhancers of HIV infection. Arnold F., Schnell J., Zirafi O., Sturzel C., Meier C., Weil T., Standker L., Forssmann W.G., Roan N.R., Greene W.C. et al. J. Virol. 86:1244-1249(2012) · Mapped (4) |
| Short-term monotherapy in HIV-infected patients with a virus entry inhibitor against the gp41 fusion peptide. Forssmann W.G., The Y.H., Stoll M., Adermann K., Albrecht U., Tillmann H.C., Barlos K., Busmann A., Canales-Mayordomo A., Gimenez-Gallego G. et al. Sci Transl Med 2:63re3-63re3(2010) · UniProtKB (36) |
| Significance of N-terminal proteolysis of CCL14a to activity on the chemokine receptors CCR1 and CCR5 and the human cytomegalovirus-encoded chemokine receptor US28. Richter R., Casarosa P., Standker L., Munch J., Springael J.Y., Nijmeijer S., Forssmann W.G., Vischer H.F., Vakili J., Detheux M. et al. J. Immunol. 183:1229-1237(2009) · Mapped (24) |
| Inhibition of CD26/dipeptidyl peptidase IV enhances CCL11/eotaxin-mediated recruitment of eosinophils in vivo. Forssmann U., Stoetzer C., Stephan M., Kruschinski C., Skripuletz T., Schade J., Schmiedl A., Pabst R., Wagner L., Hoffmann T. et al. J. Immunol. 181:1120-1127(2008) · Mapped (1) |
| Crystal structure of human epidermal kallikrein 7 (hK7) synthesized directly in its native state in E. coli: insights into the atomic basis of its inhibition by LEKTI domain 6 (LD6). Fernandez I.S., Standker L., Magert H.J., Forssmann W.G., Gimenez-Gallego G., Romero A. J. Mol. Biol. 377:1488-1497(2008) · UniProtKB (1) · Mapped (5) |
| Semen-derived amyloid fibrils drastically enhance HIV infection. Munch J., Rucker E., Standker L., Adermann K., Goffinet C., Schindler M., Wildum S., Chinnadurai R., Rajan D., Specht A. et al. Cell 131:1059-1071(2007) · UniProtKB (1) |
| Activation of human period-1 by PKA or CLOCK/BMAL1 is conferred by separate signal transduction pathways. Motzkus D., Loumi S., Cadenas C., Vinson C., Forssmann W.G., Maronde E. Chronobiol. Int. 24:783-792(2007) · Mapped (14) |
| CgNa, a type I toxin from the giant Caribbean sea anemone Condylactis gigantea shows structural similarities to both type I and II toxins, as well as distinctive structural and functional properties. Salceda E., Perez-Castells J., Lopez-Mendez B., Garateix A., Salazar H., Lopez O., Aneiros A., Standker L., Beress L., Forssmann W.-G. et al. Biochem. J. 406:67-76(2007) · UniProtKB (1) |
| Discovery and optimization of a natural HIV-1 entry inhibitor targeting the gp41 fusion peptide. Munch J., Standker L., Adermann K., Schulz A., Schindler M., Chinnadurai R., Pohlmann S., Chaipan C., Biet T., Peters T. et al. Cell 129:263-275(2007) · UniProtKB (1) |
| A new toxin from the sea anemone Condylactis gigantea with effect on sodium channel inactivation. Standker L., Beress L., Garateix A., Christ T., Ravens U., Salceda E., Soto E., John H., Forssmann W.-G., Aneiros A. Toxicon 48:211-220(2006) · UniProtKB (1) |
| Increase of expression and activation of chemokine CCL15 in chronic renal failure. Richter R., Forssmann U., Henschler R., Escher S., Frimpong-Boateng A., Forssmann W.G. Biochem. Biophys. Res. Commun. 345:1504-1512(2006) · Mapped (1) |
| Cloning, expression, and functional characterization of cynomolgus monkey (Macaca fascicularis) CC chemokine receptor 1. Gupta S., Schulz-Maronde S., Kutzleb C., Richter R., Forssmann W.-G., Kapp A., Forssmann U., Elsner J. J. Leukoc. Biol. 78:1175-1184(2005) · UniProtKB (1) |
| Quantum proteolytic activation of chemokine CCL15 by neutrophil granulocytes modulates mononuclear cell adhesiveness. Richter R., Bistrian R., Escher S., Forssmann W.G., Vakili J., Henschler R., Spodsberg N., Frimpong-Boateng A., Forssmann U. J. Immunol. 175:1599-1608(2005) · Mapped (2) |
| Characterization of human circulating TIG2 as a ligand for the orphan receptor ChemR23. Meder W., Wendland M., Busmann A., Kutzleb C., Spodsberg N., John H., Richter R., Schleuder D., Meyer M., Forssmann W.G. FEBS Lett. 555:495-499(2003) · UniProtKB (1) |
| In vivo processed fragments of IGF binding protein-2 copurified with bioactive IGF-II. Standker L., Kubler B., Obendorf M., Braulke T., Forssmann W.G., Mark S. Biochem. Biophys. Res. Commun. 304:708-713(2003) · Mapped (2) |
| Distribution of new human beta-defensin genes clustered on chromosome 20 in functionally different segments of epididymis. Rodriguez-Jimenez F.-J., Krause A., Schulz S., Forssmann W.-G., Conejo-Garcia J.-R., Schreeb R., Motzkus D. Genomics 81:175-183(2003) · UniProtKB (6) |
| Isolation and biochemical characterization of LEAP-2, a novel blood peptide expressed in the liver. Krause A., Sillard R., Kleemeier B., Kluever E., Maronde E., Conejo-Garcia J.-R., Forssmann W.-G., Schulz-Knappe P., Nehls M.C., Wattler F. et al. Protein Sci. 12:143-152(2003) · UniProtKB (6) |
| Biochemical features, molecular biology and clinical relevance of the human 15-domain serine proteinase inhibitor LEKTI. Walden M., Kreutzmann P., Drogemuller K., John H., Forssmann W.G., Hans-Jurgen M. Biol. Chem. 383:1139-1141(2002) · Mapped (3) |
| Chemical synthesis of beta-defensins and LEAP-1/hepcidin. Kluever E., Schulz A., Forssmann W.-G., Adermann K. J. Pept. Res. 59:241-248(2002) · UniProtKB (3) |
| Isolation and characterization of circulating fragments of the insulin-like growth factor binding protein-3. Kubler B., Draeger C., John H., Andag U., Scharf J.G., Forssmann W.G., Braulke T., Standker L. FEBS Lett. 518:124-128(2002) · Mapped (17) |
| LEKTI: a multidomain serine proteinase inhibitor with pathophysiological relevance. Magert H.J., Kreutzmann P., Standker L., Walden M., Drogemuller K., Forssmann W.G. Int. J. Biochem. Cell Biol. 34:573-576(2002) · Mapped (3) |
| Structure determination of human and murine beta-defensins reveals structural conservation in the absence of significant sequence similarity. Bauer F., Schweimer K., Kluever E., Conejo-Garcia J.-R., Forssmann W.-G., Roesch P., Adermann K., Sticht H. Protein Sci. 10:2470-2479(2001) · UniProtKB (4) |
| Identification of a novel, multifunctional beta-defensin (human beta-defensin 3) with specific antimicrobial activity. Its interaction with plasma membranes of Xenopus oocytes and the induction of macrophage chemoattraction. Conejo-Garcia J.-R., Jaumann F., Schulz S., Krause A., Rodriguez-Jimenez F.-J., Forssmann U., Adermann K., Kluever E., Vogelmeier C., Becker D. et al. Cell Tissue Res. 306:257-264(2001) · UniProtKB (1) |
| Human beta-defensin 4: a novel inducible peptide with a specific salt-sensitive spectrum of antimicrobial activity. Conejo-Garcia J.-R., Krause A., Schulz S., Rodriguez-Jimenez F.-J., Kluever E., Adermann K., Forssmann U., Frimpong-Boateng A., Bals R., Forssmann W.-G. FASEB J. 15:1819-1821(2001) · UniProtKB (1) |
| Natural proteolytic processing of hemofiltrate CC chemokine 1 generates a potent CC chemokine receptor (CCR)1 and CCR5 agonist with anti-HIV properties. Detheux M., Staendker L., Vakili J., Muench J., Forssmann U., Adermann K., Poehlmann S., Vassart G., Kirchhoff F., Parmentier M. et al. J. Exp. Med. 192:1501-1508(2000) · UniProtKB (1) |